In summary, the results demonstrate that while individual biomarkers such as NRG1, miR-382-5p, and lncRNA Ftx exhibit varying levels of sensitivity and specificity, their combined diagnostic potential could offer valuable insights for distinguishing between MS, NMO, and healthy controls. Here, NRG1 is linked to myeloid sarcoma.